Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.
about
Combating poor-quality anti-malarial medicines: a call to actionMalaria Diagnosis Across the International Centers of Excellence for Malaria Research: Platforms, Performance, and StandardizationThe counterfeit anti-malarial is a crime against humanity: a systematic review of the scientific evidenceAccess to artemisinin-combination therapy (ACT) and other anti-malarials: national policy and markets in Sierra LeoneA tiered analytical approach for investigating poor quality emergency contraceptivesQuality of antimalarial drugs and antibiotics in Papua New Guinea: a survey of the health facility supply chainEvaluation of a new handheld instrument for the detection of counterfeit artesunate by visual fluorescence comparisonEffective coverage and systems effectiveness for malaria case management in sub-Saharan African countriesQuality of artemisinin-based combination formulations for malaria treatment: prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, NigeriaAssessing the quality of anti-malarial drugs from Gabonese pharmacies using the MiniLabĀ®: a field studyMind the gaps--the epidemiology of poor-quality anti-malarials in the malarious world--analysis of the WorldWide Antimalarial Resistance Network database.What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism.Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countriesSubstandard drugs: a potential crisis for public health.Emerging artemisinin resistance in the border areas of Thailand.Paper analytical devices for fast field screening of beta lactam antibiotics and antituberculosis pharmaceuticals.Paper test cards for presumptive testing of very low quality antimalarial medications.Integration of novel low-cost colorimetric, laser photometric, and visual fluorescent techniques for rapid identification of falsified medicines in resource-poor areas: application to artemether-lumefantrineCollaborative health and enforcement operations on the quality of antimalarials and antibiotics in southeast Asia.Quality of antimalarials at the epicenter of antimalarial drug resistance: results from an overt and mystery client survey in Cambodia.Quality of Artemisinin-Containing Antimalarials in Tanzania's Private Sector--Results from a Nationally Representative Outlet Survey.Substandard antimalarials available in Afghanistan: a case for assessing the quality of drugs in resource poor settings.Relationship between treatment-seeking behaviour and artemisinin drug quality in Ghana.Distribution of human CYP2C8*2 allele in three different African populationsQuality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their useRisks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western KenyaThe diagnostic accuracy of the hand-held Raman spectrometer for the identification of anti-malarial drugs.Methods for implementing a medicine outlet survey: lessons from the anti-malarial marketPlasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity.Modeling Key Malaria Drugs' Impact on Global Health: A Reason to Invest in the Global Health Impact Index.Adverse drug events resulting from use of drugs with sulphonamide-containing anti-malarials and artemisinin-based ingredients: findings on incidence and household costs from three districts with routine demographic surveillance systems in rural TanzEthical challenges in designing and conducting medicine quality surveys.A pilot study on quality of artesunate and amodiaquine tablets used in the fishing community of Tema, GhanaAzadirachta indica ethanolic extract protects neurons from apoptosis and mitigates brain swelling in experimental cerebral malaria.Development of a simple and specific direct competitive ELISA for the determination of artesunate using an anti-artesunate polyclonal antiserumMalaria elimination: surveillance and response.A review of existing and emerging digital technologies to combat the global trade in fake medicines.Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.A link between poor quality antimalarials and malaria drug resistance?Estimated under-five deaths associated with poor-quality antimalarials in sub-Saharan Africa.
P2860
Q24658634-947BDD4F-E8E7-4FF8-9CBD-37C86D9B4FE9Q26799721-7800110F-2651-48AB-9FA3-729AE8A6DD2CQ26828002-CE33BBD5-2B09-4569-A401-AC47842C3D77Q28484648-608132A1-886E-4A2F-BA4F-07BFD848B839Q28538040-F5B5D511-7C1A-4DB1-9BF2-8811048C09E0Q28538830-DED2679F-1ACB-4AF9-88CE-4CA06580F0F7Q28544869-CAB9BD2C-5047-45AB-BD6A-3A8FEE35921EQ28547444-956A714C-F858-47F3-A943-3417F8FEC3A5Q28547513-13DB48A0-DBFD-421A-ADEB-B11A0BDFBECFQ28647142-1C6AE750-0E98-49A5-8892-31D2F1D7E7EDQ30486867-1618BA27-B6B2-47D4-90A6-7AB30E21A3E0Q33604549-7B4B98C8-E27B-435E-85FE-FCB42F8E764BQ33726606-73C5A5B9-5E02-4CA6-8343-E362EE8DE0A3Q34065256-85CFB82C-E3E8-49DA-85E8-C41E8131D6D0Q34343530-EB4BA7E0-CABC-4ACB-BE78-84436CEA175EQ34750498-4EF67A86-0142-4973-8612-1BD799F3D581Q35610540-A2A8554A-9D61-4D27-ABC8-538B6E45EAAEQ35610545-1FC8F348-996B-4FC0-9C58-479CFF079526Q35610549-F6A4BEB1-9508-4584-B930-93D326FA4901Q35681778-E2BEFA4E-6B4D-45BA-ADD0-96E4168F5EBDQ35681798-E8BE52AF-0376-4D4A-BD86-F0A1752AEB1EQ35681822-DAB2233E-AF18-46D8-AB68-649648ADC853Q35920087-6F8639B9-EA57-4A0F-B145-B14AA0EBBD07Q35963368-0C3016E1-BCC4-41B4-B75A-9EB751837610Q36176551-C0F13D9C-B771-4166-903F-21C7E2DCC8DEQ36298460-9030B5F2-2E9F-494F-B5D3-408D88CACBA8Q36686951-670F22BE-C4F6-4590-ABA7-6864285B1160Q36690617-10847BBB-57EB-4839-9182-F86BAA6709A6Q36796548-31A0B8BB-8C28-45F2-9855-805F851C65A8Q36869616-3B847276-A5DE-453D-951C-B7858083B11FQ37009500-0D406A63-D31A-4D27-AC25-F506F261B86DQ37020706-3BDDF436-AA3A-4CAE-8AD7-0248CA8A1AD5Q37042313-AB92B6E2-EDB0-4FD0-A3F0-217AD978AE6DQ37351723-E7B33A01-6B91-47E3-A5A2-B84D221814BCQ37425176-110F0313-2D15-4DAE-BA82-30BADF253935Q37726763-2467E4D2-3F18-42CF-A613-327336A3CA78Q38738669-796B1379-217D-453D-ABF2-8D6184BADE7FQ38867438-97901663-1DB4-4690-A2EC-AF55C8917693Q39300954-ECDC7310-C926-48C7-8CCF-0C824E2E8EB7Q39393283-6043C61F-B2F6-4C74-99B6-2C876B58B47A
P2860
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.
description
2011 nĆ® lÅ«n-bĆ»n
@nan
2011幓ć®č«ę
@ja
2011幓č«ę
@yue
2011幓č«ę
@zh-hant
2011幓č«ę
@zh-hk
2011幓č«ę
@zh-mo
2011幓č«ę
@zh-tw
2011幓č®ŗę
@wuu
2011幓č®ŗę
@zh
2011幓č®ŗę
@zh-cn
name
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.
@ast
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.
@en
type
label
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.
@ast
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.
@en
prefLabel
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.
@ast
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.
@en
P2093
P2860
P50
P356
P1433
P1476
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.
@en
P2093
Abdinasir A Amin
Aline PlanƧon
Ans E Timmermans
Claude Faurant
Dana M Hostetler
Facundo M FernƔndez
Glenn A Harris
Harparkash Kaur
Henry Nettey
Isabel Swamidoss
P2860
P2888
P356
10.1186/1475-2875-10-352
P577
2011-12-13T00:00:00Z
P5875
P6179
1005803900